FierceBiotech Announces Drug Development Forum

WASHINGTON, DC--(Marketwired - May 11, 2016) - FierceBiotech, the most highly regarded media and news outlet in the biotech market, announced today that registration is now open for the FierceBiotech Drug Development Forum (DDF). This multi-day conference with exhibits will take place September 19-21 at the InterContinental Hotel in Boston, Massachusetts. The event will bring together leading pharmaceutical and biotech professionals to discuss and evaluate the latest challenges, trends and innovation in drug discovery, research, and development. Registration is available at fiercedrugdevforum.com/attend.

"This conference has been years in the making and we are excited to finally bring the Drug Development Forum to our audience," says Rebecca Willumson, Publisher of FierceBiotech. "Our primary objective behind this conference is to build a program for the industry, by the industry and we've been working very closely with our advisory board, our readers, and key industry leaders to develop a program that digs into the real issues facing our industry today." 

FierceBiotech has brought decades of success to the industry by providing insightful content and useful resources to its subscribers. Expanding on the success of the publication, the Drug Development Forum will drive strategic relationships and process improvements throughout the drug development process to attendees, sponsors, and more. Pharma and biotech executives from C-suite to research and operations will gather at the event, including those involved in: Clinical Operations, Clinical Research, Clinical Trial Management, Laboratory R&D, Pharmacovigilance/Regulatory, Strategic Sourcing Strategy, Innovation, and Investment.

Partnered with some of the industry's leading players, FierceBiotech has worked with its Advisory Board to develop a world-class conference program. Three distinct tracks -- R&D, Partnering & Deals, and Outsourcing -- will provide insight into multiple aspects of the drug development process. These tracks will be covered in a variety of formats from inspiring Keynote and General Sessions to exciting and interactive Panel Discussions. Stay tuned for the full program to be announced in late May.

A focused exhibition will showcase the top companies in the drug discovery and development industry and will allow attendees to explore this showcase of technology throughout the event. Current sponsors include: BioTech Primer, INC Research, PPD, PwC, and SynteractHCR. In addition to sponsor visits, the Forum will also feature invaluable networking opportunities for attendees to meet, learn, and get inspired by the top pharma and biotech innovators at Networking Lunches, as well as special Awards Receptions celebrating the Fierce 15 Awards and Women in Bio.

To learn more about the Drug Development Forum and Early Bird Registration, please visit fiercedrugdevforum.com/attend. 

Space is limited and sponsorships are selling out fast. If you're interested in signing up as a sponsor, contact Angelique Alcover at aalcover@fiercemarkets.com. To see the complete list of sponsors or to learn more about the event, please visit fiercedrugdevforum.com/all-sponsors.

About FierceBiotech
The Drug Development Forum is produced by Questex, owners of FierceBiotech and FierceMarkets. FierceBiotech is the biotech industry's daily monitor, an email newsletter and web resource providing the latest biotech news, articles, and resources related to clinical trials, drug discovery, FDA approval, FDA regulation, patent news, pharma news, biotech company news and more. More than 150,000 top biotech professionals rely on FierceBiotech for an Insider briefing on the day's top stories. Learn more at fiercebiotech.com. Questex has extensive event management experience with over 400 employees in the United States, Europe, and Asia. Learn more at questex.com.